BioNTech SE: Positive Phase 1 Data from mRNA-based Individua

Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United

Related Keywords

United States , Germany , New York , Memorial Sloan Kettering Cancer Center , Chicago , Illinois , American , Sylke Maas , Vinod Balachandran , Fosun Pharma , Autogene Cevumeran , Genentech , American Society Of Clinical Oncology , Nasdaq , Pfizer , Vp Corporate Communications , Roche Group , American Society , Clinical Oncology , Annual Meeting , Memorial Sloan Kettering Cancer , Chief Medical Officer , Phasei Trial , Pancreatic Ductal , Good Manufacturing Practice , New Technologies , Private Securities Litigation Reform Act , Annual Report , Year Ended December , Biontech , Positive , Hase , Data , Rom , Rna , Ased , Individualized , Eoantigen , Specific , Immunotherapy , Patients , Nresected , Pancreatic , Dancer , Resented , Disco ,